Statistical modeling using preoperative prognostic variables in predicting extracapsular extension and progression after radical prostatectomy for prostate cancer

被引:11
作者
Bauer, JJ [1 ]
Connelly, RR [1 ]
Seterhenn, IA [1 ]
Srivastava, S [1 ]
McLeod, DG [1 ]
Moul, JW [1 ]
机构
[1] Walter Reed Army Med Ctr, Dept Surg, Urol Serv, Washington, DC 20307 USA
关键词
D O I
10.1093/milmed/163.9.615
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To predict the risk of extracapsular extension and postoperative recurrence before radical prostatectomy (RP) for prostate cancer. Methods: We performed multivariate Cox regression analysis on preoperative variables in 260 clinically localized prostate cancer patients who underwent RP. With these data, we constructed a relative risk of recurrence (R-r) equation and an equation to predict the probability of extracapsular extension (P-ECE) before RP. Results: R-r is calculated as exp[(0.47 x race + 0.14 x PSA(ST)) + (0.13 x worst biopsy Gleason sum) + (1.03 x stage Tlc) + (1.55 x stage T2b,c)], where PSA(ST) indicates a sigmoidal transformation of prostate-specific antigen. P-ECE is calculated as 1/[1 + exp(-Z)], where Z = -2.47 + 0.15 (PSA(ST)) + 0.31 (worst biopsy Gleason sum) + 0.18 (race) + 0.16 (stage Tlc) + 0.38 (stage T2b,c). Conclusion: These two equations can be used preoperatively to predict the probability of extracapsular disease and the risk of prostate-specific antigen recurrence in patients undergoing RP.
引用
收藏
页码:615 / 619
页数:5
相关论文
共 26 条
[1]  
[Anonymous], 1980, Histological typing of prostate tumours / F. K. Mostofi, in collaboration with I. Sesterhenn
[2]  
[Anonymous], UROLOGIC PATHOLOGY
[3]   Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer [J].
Bauer, JJ ;
Connelly, RR ;
Seterhenn, IA ;
Deausen, J ;
Srivastava, S ;
McLeod, DG ;
Moul, JW .
JOURNAL OF UROLOGY, 1998, 159 (03) :929-933
[4]  
Bauer JJ, 1995, CLIN CANCER RES, V1, P1295
[5]   Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer [J].
Bauer, JJ ;
Sesterhenn, IA ;
Mostofi, FK ;
McLeod, DG ;
Srivastava, S ;
Moul, JW .
JOURNAL OF UROLOGY, 1996, 156 (04) :1511-1516
[6]   Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy [J].
Bettencourt, MC ;
Bauer, JJ ;
Sesterhenn, IA ;
Mostofi, FK ;
McLeod, DG ;
Moul, JW .
JOURNAL OF UROLOGY, 1996, 156 (03) :1064-1068
[7]   STATISTICAL-METHODS FOR CENSORED SURVIVAL-DATA [J].
BRESLOW, N .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1979, 32 (OCT) :181-192
[8]  
COX DR, 1972, J R STAT SOC B, V34, P187
[9]   A MULTIVARIABLE ANALYSIS OF CLINICAL FACTORS PREDICTING FOR PATHOLOGICAL FEATURES ASSOCIATED WITH LOCAL FAILURE AFTER RADICAL PROSTATECTOMY FOR PROSTATE-CANCER [J].
DAMICO, AV ;
WHITTINGTON, R ;
MALKOWICZ, SB ;
SCHNALL, M ;
TOMASZEWSKI, J ;
SCHULTZ, D ;
KAO, G ;
VANARSDALEN, K ;
WEIN, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 30 (02) :293-302
[10]  
EPSTEIN JI, 1993, CANCER-AM CANCER SOC, V71, P3582, DOI 10.1002/1097-0142(19930601)71:11<3582::AID-CNCR2820711120>3.0.CO